Stay updated on Acute Kidney Injury in Dapagliflozin vs Other Antidiabetics Clinical Trial
Sign up to get notified when there's something new on the Acute Kidney Injury in Dapagliflozin vs Other Antidiabetics Clinical Trial page.

Latest updates to the Acute Kidney Injury in Dapagliflozin vs Other Antidiabetics Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedDifference35%

- Check15 days agoChange DetectedThe page now shows a new revision tag in the footer. A large block of IPD sharing and sponsor-related disclosures, including AstraZeneca links, has been removed.SummaryDifference14%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page shows an updated revision tag, changing from v3.6.3 to v3.6.4, reflecting a minor internal update to the page version.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, signaling a minor update or patch to the page. This change does not alter the study content or the visible information presented to users.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page shows a revision update from v3.6.0 to v3.6.2, indicating a small software update to the interface. This update does not alter the study details or how the page presents study information.SummaryDifference0.1%

- Check73 days agoChange DetectedThe study page now shows recruitment as 'No longer looking for participants' and adds help sections (How to Read a Study Record, Common Questions, How to Join a Study), with the revision updated to v3.6.0.SummaryDifference0.5%

Stay in the know with updates to Acute Kidney Injury in Dapagliflozin vs Other Antidiabetics Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Acute Kidney Injury in Dapagliflozin vs Other Antidiabetics Clinical Trial page.